Maximus, Inc. (NYSE:MMS) Announces $0.30 Quarterly Dividend

Maximus, Inc. (NYSE:MMS - Get Free Report) announced a quarterly dividend on Monday, July 7th, RTT News reports. Investors of record on Friday, August 15th will be given a dividend of 0.30 per share by the health services provider on Sunday, August 31st. This represents a $1.20 annualized dividend and a yield of 1.69%.

Maximus has a payout ratio of 18.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 20.8%.

Maximus Stock Performance

MMS traded down $0.12 during trading on Tuesday, hitting $71.18. The stock had a trading volume of 51,489 shares, compared to its average volume of 570,659. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.87. The firm has a market cap of $4.01 billion, a PE ratio of 14.16 and a beta of 0.61. The company has a 50 day simple moving average of $71.25 and a 200-day simple moving average of $70.94. Maximus has a 12 month low of $63.77 and a 12 month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a net margin of 5.56% and a return on equity of 23.37%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the previous year, the firm posted $1.57 earnings per share. Maximus's revenue for the quarter was up 1.0% compared to the same quarter last year. Analysts expect that Maximus will post 6.15 EPS for the current year.

Insider Buying and Selling

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the company's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Royal Bank of Canada increased its holdings in shares of Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider's stock valued at $1,345,000 after purchasing an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. Jane Street Group LLC lifted its holdings in Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider's stock valued at $6,701,000 after acquiring an additional 88,835 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Maximus by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider's stock worth $12,321,000 after purchasing an additional 11,754 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.